> Good for Pfizer for showing some cajones.

Well, you could also view this from the opposite angle: if they didn't block this, how good would it look on them?

Also, I can't help but wonder what their stance would be if the "execution" market was much larger.

Anyway, I still applaud this move of course, that is not the point.

This is just a continuation of Hospira's policy. Pfizer purchased Hospira a year or two back.

If you think about it from a PR move, it's a low risk move.

The Secretary of the Treasury is currently a Democrat. While I don't think he's taken a position on the death penalty, Democrats tend to be anti-capital punishment and this would be a pretty bizarre way to thumb your nose at a Democrat. Even Democrats who claim to be pro-death penalty would likely privately be happy about this.

This is the opposite of showing cajones. Manufacturers of these drugs have been sued because their drugs were used for executions. So this is a attempt to avoid liability.